The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine Leiomyosarcomas.
Clin Cancer Res. 2020 Feb 15;26(4):855-861. doi: 10.1158/1078-0432.CCR-19-2891. Epub 2019 Dec 3.
Clin Cancer Res. 2020.
PMID: 31796515